Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows revision v3.5.4 instead of v3.5.3, indicating a small site update to the interface or backend.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page indicates an update of its site/portal release version from v3.5.0 to v3.5.3, reflecting a backend or tooling revision rather than any new or modified study information.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-facing study details or layout changes are evident.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check94 days agoChange DetectedA minor maintenance update was applied, adding Revision v3.4.2 and removing v3.4.1. This change does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check101 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; no substantive content changes to the study details page were observed. This seems to be an internal version bump rather than a modification to user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.